Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-06-16

FDA Approved: ELETRIPTAN HYDROBROMIDE — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved the original application for Eletriptan hydrobromide from Zydus Pharmaceuticals USA Inc., establishing a generic option for the acute treatment of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eletriptan Hydrobromide (eletriptan hydrobromide)

Snippet

ORIG AP for ELETRIPTAN HYDROBROMIDE (ELETRIPTAN HYDROBROMIDE)